Citrate D’yttrium [90y] Cis Bio International

Yttrium (90y) Citrate is a radiopharmaceutical used for targeted radiation therapy. This product by Cis Bio International is designed for intraarticular use, offering a specialized approach to localized treatment.

Yttrium (90y) Citrate is primarily used in radiation therapy to deliver targeted treatment. It is administered intraarticularly, making it suitable for conditions requiring localized radiation. This radiopharmaceutical is often considered for its ability to deliver precise radiation doses directly to the affected area.

Yttrium (90y) Citrate works by emitting beta radiation, which can help in reducing abnormal cell growth. Patients may experience localized effects due to the targeted nature of the treatment. The specific effects can vary based on individual conditions and the area being treated.

Handling Yttrium (90y) Citrate requires strict adherence to safety protocols due to its radioactive properties. It should only be administered by trained healthcare professionals in a controlled environment. Proper shielding and protective measures are essential to minimize exposure risks.

Yttrium (90y) Citrate may interact with other medications or treatments, particularly those involving radiation or certain chemotherapy agents. It is important to disclose all current treatments to the healthcare provider to avoid potential interactions. Alcohol and other substances should be discussed with a medical professional before use.